Exome sequencing identifies the first genetic determinants of sirenomelia in humans.
François LecoquierreAnne-Claire BrehinSophie CoutantJuliette CoursimaultAnne BazinWilfrid FinckGuillaume BenoistMarianne BegorreClaire BeneteauDaniel CailliezPierre ChenalMirjam De JongSophie DegréLouise DevismeChristine FrancannetBénédicte GérardCorinne JeanneMadeleine JoubertHubert JournelHélène Laurichesse DelmasValérie LayetAlain LiquierRaphaele MangioneSophie PatrierFanny PelluardFlorence PetitNadia TilloucheConny van Ravenswaaij-ArtsThierry FrebourgPascale Saugier-VeberNicolas GruchyGaël NicolasMarion GerardPublished in: Human mutation (2020)
Sirenomelia is a rare severe malformation sequence of unknown cause characterized by fused legs and severe visceral abnormalities. We present a series of nine families including two rare familial aggregations of sirenomelia investigated by a trio-based exome sequencing strategy. This approach identified CDX2 variants in the two familial aggregations, both fitting an autosomal dominant pattern of inheritance with variable expressivity. CDX2 is a major regulator of caudal development in vertebrate and mouse heterozygotes are a previously described model of sirenomelia. Remarkably, the p.(Arg237His) variant has already been reported in a patient with persistent cloaca. Analysis of the sporadic cases revealed six additional candidate variants including a de novo frameshift variant in the genetically constrained NKD1 gene, encoding a known interactor of CDX2. We provide the first insights for a genetic contribution in human sirenomelia and highlight the role of Cdx and Wnt signaling pathways in the development of this disorder.
Keyphrases
- copy number
- mitochondrial dna
- genome wide
- early onset
- single cell
- dna methylation
- late onset
- endothelial cells
- signaling pathway
- stem cells
- cell proliferation
- case report
- transcription factor
- induced pluripotent stem cells
- drug induced
- oxidative stress
- amyotrophic lateral sclerosis
- epithelial mesenchymal transition
- type diabetes